March 10, 2011 Human Genome Sciences, Inc. and GlaxoSmithKline received approval from the FDA for Benlysta (belimumab) for the treatment of autoantibody-positive systemic lupus erythematosus (SLE) in patients receiving standard therapy.
March 9, 2011 Aeterna Zentaris, Inc. and Yakult Honsha Co. have signed an exclusive development, commercialization and licensing agreement for Aeterna Zentaris' lead anti-cancer compound perifosine, in Japan.
March 8, 2011 RainDance Technologies, Inc. and Ambry Genetics have entered a collaboration focused on the development and commercialization of a comprehensive drug absorption, distribution, metabolism, and excretion (ADME) genetic screening panel.
March 8, 2011 Eisai, Inc., a U.S. subsidiary of Eisai Co., Ltd., plans to restructure its operations, cutting approximately 20% of its workforce across all U.S. functions, resulting in the loss of 600 positions by April 1, 2011.
March 7, 2011 Bristol-Myers Squibb and WuXi PharmaTech have entered a strategic partnership to conduct stability studies of small-molecule new chemical entities to support global marketing applications.
March 7, 2011 Covance, Inc. was awarded full accreditation for its early development research facility in Shanghai, China from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).
March 7, 2011 GEA Pharma Systems has partnered with Christian Berner Tech Trade to sell its range of GEA solid dosage technologies in Sweden and Norway, expanding GEA Pharma’s market reach in the region.